Status:
COMPLETED
Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions:
Major Depressive Disorder
Antidepressant Treatment Response
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to examine whether the speed of the clinical antidepressant action of citalopram can be accelerated by administering double doses of pindolol (15 mg/day, tid) which presum...
Detailed Description
Design, Settings, and Participants. A randomised, double-blind, placebo-controlled trial with MDD patients allocated to two treatment arms: citalopram + pindolol versus citalopram + placebo. Participa...
Eligibility Criteria
Inclusion
- Patients with a depressive episode
- HDRS score \> 18
- Written informed consent
Exclusion
- suicidal risk \> 3
- severe organic illness
- other psychotropic drugs
Key Trial Info
Start Date :
December 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2005
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00931775
Start Date
December 1 2002
End Date
November 1 2005
Last Update
July 2 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Outpatients Service of Psychiatry Department. Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, Spain, 08025